Pharma Pulse 5/8/24: Navigating the Long, Bumpy Road to Rare Disease Diagnosis and Treatment, ‘Deepfake’ Detector to Disinformation & more

Cencora VP of Emerging Therapies Discusses Cell & Gene Therapy Distribution Strategies

In an interview with Pharm Exec Associate Editor Don Tracy, Melissa Lattanzi, VP, Emerging Therapies, Cencora, offers a synopsis on what questions cell and gene therapy developers need to answer to inform their distribution strategy.

Navigating the Long, Bumpy Road to Rare Disease Diagnosis and Treatment

A patient details his experience juggling the roles of caregiver of his wife with cancer and patient struggling to receive a diagnosis for a rare disease.

OpenAI Releases ‘Deepfake’ Detector to Disinformation Researchers

The prominent A.I. start-up is also joining an industrywide effort to spot content made with artificial intelligence.

CG Life Appoints Jon Sawyer as Chief Operating Officer to Support Strategic Growth and Integration

CG Life, a science-first, tech-enabled agency for life science, has expanded its leadership team to welcome Jon Sawyer as the agency’s Chief Operating Officer. Sawyer brings more than 20 years of leadership in healthcare marketing to the role and will draw on this deep experience to manage CG Life's operations as the agency partners with established and emerging organizations in life sciences and biopharma.

PicnicHealth on LinkedIn:

🔍 Observational research, simplified.

In Pharmaceutical Executive's new Q&A with our Chief Scientific Advisor, Nancy A. Dreyer discusses how PicnicHealth is changing the game by simplifying observational research and driving greater efficiency.

Read the full Q&A here: https://lnkd.in/eXRqtiD3

And if your attending #ispor2024, don't miss Nancy's presentation Tuesday, May 7th, at 3:15 pm. Click here for event details: https://lnkd.in/gk33EYCy

Have news you want us to share in Pharma Pulse? Reach out to Social Media Editor Miranda Schmalfuhs